Incyte Biosciences Japan GK
6 clinical trials · Sponsor
◉ Watch Incyte Biosciences Japan GK
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of INCB054707 (NCT05068466) | Incyte Biosciences Japan GK | 2021-10-21 |
| To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 (NCT04674748) | Incyte Biosciences Japan GK | 2021-02-03 |
| To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) (NCT04661007) | Incyte Biosciences Japan GK | 2020-12-15 |
| Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213) (NCT04434937) | Incyte Biosciences Japan GK | 2020-09-30 |
| A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors (NCT03910530) | Incyte Biosciences Japan GK | 2019-07-22 |
Track Incyte Biosciences Japan GK automatically
Every clearance here is in the API, with alerts when new ones post.